http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9218477-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfabea9cec0f7fec7b1871ba730c4e64
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-12
filingDate 1992-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c441ccbefc7ae4a9914b07ab0e33641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b57b1e0d4272239e6b7acc375592545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f63fa54af7a58c1fc24a548bd23487c
publicationDate 1992-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9218477-A1
titleOfInvention Azabicycloheptanone
abstract The individual enantiomers of the bicyclic β-lactam compounds (Ia), (Ib), (IIa) or (IIb), optionally substituted by non-interfering substituent(s). The novel enantiomers can be obtained by biotransformation. The Ia or IIa compounds can be used for the synthesis of chiral cis-pentacin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9910519-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0058283-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0571870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AP-1104-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1133749-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6340587-B1
priorityDate 1991-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0424064-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226522280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226857460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235112036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129380005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226522279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128056062
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129623204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129950273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127601456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6454737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226509365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229074013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228304246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128522257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67917954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12870589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19075556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID272730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID548678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129532109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226463884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127720350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8882

Total number of triples: 55.